Probiotics modulate inflammatory cytokine secretion from inflamed mucosa in active ulcerative colitis

被引:54
作者
Bai, AP
Ouyang, Q [1 ]
Xiao, XR
Li, SF
机构
[1] Sichuan Univ, Westchina Hosp, Dept Gastroenterol, Chengdu 610041, Peoples R China
[2] Sichuan Univ, Huaxi Sch Stomatol, Dept Microbiol, Chengdu 610064, Peoples R China
[3] Sichuan Univ, Huaxi Hosp, Inst Transplantat & Immunol, Chengdu 610064, Peoples R China
关键词
probiotics; ulcerative colitis; cytokine; nuclear factor-kappa B (NF-kappa B);
D O I
10.1111/j.1368-5031.2006.00833.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Enteric microflora of ulcerative colitis patients becomes aberrant. The abnormal interaction between microflora and intestinal mucosal immune system leads the mucosal inflammation. Probiotic administration may recover the commensal microflora and normalise the host-microbial interaction. In this experiment, we cocultured colonic biopsies from active ulcerative colitis patients with bifidobacterium to investigate the modulation effect of probiotics on inflamed colonic. tissues and its possible mechanism. Colonic biopsies from active ulcerative colitis were cocultured for 24 h with Bifidobacterium longum. Tumour necrosis factor (TNF)-alpha and interleukin (IL)-8 in supernatants were measured using enzyme-linked immunosorbent assays, the biopsies were fixed using paraffin and the expression of NF-kappa B P65 of tissues was studied using immunohistochemical staining. The concentrations of TNF-alpha and IL-8 in supernatants of tissues cocultured with probiotics were lower than those cultured alone. The number of lamina propria mononuclear cells (LPMC) with nuclear factor-kappa B (NF-kappa B) P65 positive in cocultured tissues was also decreased. When cocultured with inflamed tissues of active ulcerative colitis, probiotics could inhibit NF-kappa B activation in LPMC and down-regulate inflammatory cytokine secretion from inflamed tissues of active ulcerative colitis.
引用
收藏
页码:284 / 288
页数:5
相关论文
共 30 条
[1]   A mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29 [J].
Adlerberth, I ;
Ahrne, S ;
Johansson, ML ;
Molin, G ;
Hanson, LA ;
Wold, AE .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1996, 62 (07) :2244-2251
[2]  
Bai AP, 2004, WORLD J GASTROENTERO, V10, P455
[3]   Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease [J].
Banks, C ;
Bateman, A ;
Payne, R ;
Johnson, P ;
Sheron, N .
JOURNAL OF PATHOLOGY, 2003, 199 (01) :28-35
[4]   Increased mucosal tumour necrosis factor α production in Crohn's disease can be downregulated ex vivo by probiotic bacteria [J].
Borruel, N ;
Carol, M ;
Casellas, F ;
Antolín, M ;
de Lara, F ;
Espín, E ;
Naval, J ;
Guarner, F ;
Malagelada, JR .
GUT, 2002, 51 (05) :659-664
[5]   TUMOR-NECROSIS-FACTOR ALPHA-PRODUCING CELLS IN THE INTESTINAL-MUCOSA OF CHILDREN WITH INFLAMMATORY BOWEL-DISEASE [J].
BREESE, EJ ;
MICHIE, CA ;
NICHOLLS, SW ;
MURCH, SH ;
WILLIAMS, CB ;
DOMIZIO, P ;
WALKERSMITH, JA ;
MACDONALD, TT .
GASTROENTEROLOGY, 1994, 106 (06) :1455-1466
[6]  
Cummings J H, 2003, Curr Issues Intest Microbiol, V4, P9
[7]  
Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448
[8]   Probiotics and the management of inflammatory bowel disease [J].
Fedorak, RN ;
Madsen, KL .
INFLAMMATORY BOWEL DISEASES, 2004, 10 (03) :286-299
[9]   Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial [J].
Gionchetti, P ;
Rizzello, F ;
Venturi, A ;
Brigidi, P ;
Matteuzzi, D ;
Bazzocchi, G ;
Poggioli, G ;
Miglioli, M ;
Campieri, M .
GASTROENTEROLOGY, 2000, 119 (02) :305-309
[10]  
Isolauri E, 2002, GUT, V50, P54, DOI 10.1136/gut.50.suppl_3.iii54